This trial will test whether genetic testing for Familial Hypercholesterolemia (FH) in patients admitted to hospital with an acute coronary syndrome will increase the diagnosis of FH and improve patient care and outcomes.
1 Primary · 3 Secondary · Reporting Duration: 1 year
Active Control
Experimental Treatment
250 Total Participants · 2 Treatment Groups
Primary Treatment: Research-based genetic test for Familial Hypercholesterolemia · No Placebo Group · N/A
Age 18 - 60 · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: